Basics
Description
- Also known as German measles or 3 " “day measles
- Transmission via droplets from respiratory secretions
- Moderately contagious:
- Especially during rash eruption and infants with congenital rubella syndrome (CRS)
- Up to 50% may be subclinical.
- Infants with congenital rubella shed large quantities of virus for several months.
- Infectious period 7 days before to 5 days after appearance of rash
- Incubation period: 14 " “21 days
Etiology
- Rubella virus (family: Togaviridae, genus: Rubivirus)
- Live, attenuated virus vaccine indications:
- All children >12 mo and entering school
- All women of childbearing age
Diagnosis
Signs and Symptoms
- Acute viral disease
- Complications:
- Uncommon, tend to occur more in adults
- CRS: Infected women in 1st trimester (hearing loss, mental retardation, cardiovascular defect, ocular defect)
- Arthritis:
- More common in women (up to 79%)
- Chronic arthritis is rare.
- Begins after 2 " “3 days of illness
- Knees, wrists, fingers affected
- Hemorrhagic manifestations:
- Secondary to thrombocytopenia
- More common in children
- Neurologic sequelae:
- Encephalitis most common in adults; prognosis usually good
- No causal relationship to autism
History
- Low-grade fever
- Malaise
- Headache
- Upper respiratory tract symptoms
Physical Exam
- Rash:
- Rash is fainter than measles rash and does not coalesce.
- Red macular rash evolving to pink-red maculopapules with occasional pruritus
- Begins in face with rapid caudal spread
- Completed in 1st day and disappears in 3 days
- May have hemorrhagic manifestations
- Lymphadenopathy:
- Postauricular
- Occipital
- Posterior cervical
Essential Workup
Generally clinical diagnosis ‚
Diagnosis Tests & Interpretation
Lab
- CBC:
- Decreased WBC, platelets (more common in children)
- Urinalysis:
- Reverse transcriptase " “polymerase chain reaction
- ELISA to detect rubella IgM
- Rubella antibody titer:
- Acute and convalescent serum specimens
- Hemagglutination-inhibition test most common
- Rubella specific IgM antibodies using enzyme immunoassay (EIA) commercially available. Detectable 4 days after onset of rash
- Definitive diagnosis in acute infection
- Compare infant with maternal sera for CRS.
- False positives in parvovirus, infectious mononucleosis, rheumatoid factor
- May be useful to check for immunity of pregnant patients with potential exposure.
- Pharynx:
- Virus may be isolated from pharynx 1 wk before and until 2 wk after rash onset (valuable epidemiologic tool).
- CSF:
- Few WBCs (monocytes) in encephalitis
Diagnostic Procedures/Surgery
- Lumbar puncture if suspected encephalitis
- Arthrocentesis in unexplained arthritis.
Differential Diagnosis
- Scarlet fever:
- "Sandpaper " ť rash, Pastia lines, and strawberry tongue
- Measles (rubeola):
- Koplik spots, cough, coryza, conjunctivitis, and fever
- Roseola infantum:
- Rocky Mountain spotted fever:
- Rash begins at ankles and wrists.
- Rheumatoid arthritis
Treatment
Pre-Hospital
Use N95 filter mask for potential respiratory transmission. ‚
Initial Stabilization/Therapy
ABC management ‚
Ed Treatment/Procedures
- Symptomatic therapy
- Antipyretics and anti-inflammatory agents:
- Isolate rubella patients from susceptible persons (e.g., pregnancy).
- Vaccine:
- Measles, mumps, and rubella vaccine
- Rubella vaccine is live attenuated virus.
- Indications:
- >12 mo and entry to school
- Susceptible postpubertal females
- High-risk groups (colleges, military, places of employment)
- Unimmunized contacts
- Healthcare workers and women of childbearing age born after 1957
- Nonpregnant women may have arthralgia in up to 25%
- Contraindicated in pregnant women
- Avoid pregnancy for 3 mo after vaccination.
- 1 dose confers probable lifelong protection.
- Common complaints are fever, lymphadenopathy, and arthralgia.
- Immunoglobulin:
- Will not prevent viremia but may modify symptoms
Medication
- Acetaminophen: 500 mg (peds: 15 mg/kg/dose) PO q4h; do not exceed 5 doses/24 h or 4 g/24 h
- Ibuprofen: 200 " “600 mg (peds: 5 " “10 mg/kg PO q6 " “8h); suspension 100 mg/5 mL; oral drops 40 mg/mL
- Immunoglobulin: 0.5 mL reconstituted vial SC (0.25 " “0.50 mL/kg)
Follow-Up
Disposition
Admission Criteria
Discharge Criteria
- Most patients may go home.
- Inquire regarding vaccination status of family members.
Issues for Referral
- Potential exposure or disease in pregnant women
- Complications
- CRS-suspected child will need comprehensive evaluation.
Followup Recommendations
Pregnant women with suspected rubella or exposure must be followed with titers and counseling should have obstetric consult. ‚
Pearls and Pitfalls
- Current literature does not support a causal relationship between childhood vaccination with thimerosal-containing vaccines and development of autism-spectrum disorders.
- Infected individual should be isolated from susceptible (pregnancy, immunocompromised) individual for 7 days.
Additional Reading
- American Academy of Pediatrics. Report of the Committee on Infectious Diseases. 29th ed. Elk Grove, IL: American Academy of Pediatrics; 2012.
- Banatvala ‚ JE, Brown ‚ DW. Rubella. Lancet. 2004;363:1127 " “1137.
- Gerber ‚ JS, Offit ‚ PA. Vaccines and autism: A tale of shifting hypotheses. Clin Infect Dis. 2009;48:456 " “461.
- Mason ‚ WH. Rubella. In: Kliegman ‚ RM, Behrman ‚ RE, Jenson ‚ HB, et al., eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: WB Saunders; 2007:1337 " “1340.
Codes
ICD9
- 056.9 Rubella without mention of complication
- 647.50 Rubella in the mother, unspecified as to episode of care or not applicable
- 771.0 Congenital rubella
- 056.71 Arthritis due to rubella
- 056.00 Rubella with unspecified neurological complication
- 056.01 Encephalomyelitis due to rubella
- 056.79 Rubella with other specified complications
- 056.8 Rubella with unspecified complications
ICD10
- B06.9 Rubella without complication
- O35.3XX0 Maternal care for (suspected) damage to fetus from viral disease in mother, not applicable or unspecified
- P35.0 Congenital rubella syndrome
- B06.82 Rubella arthritis
- B06.00 Rubella with neurological complication, unspecified
- B06.01 Rubella encephalitis
- B06.89 Other rubella complications
SNOMED
- 36653000 Rubella (disorder)
- 1857005 Congenital rubella syndrome (disorder)
- 84939004 Rubella in mother complicating pregnancy, childbirth AND/OR puerperium
- 19431000 Rubella arthritis (disorder)
- 186567003 Rubella with neurological complication (disorder)
- 240485004 Hemorrhagic rubella (disorder)